ACOG委员会意见第734号摘要:经阴道超声在评估绝经后出血妇女子宫内膜中的作用
该委员会意见阐述经阴道超声在绝经后出血评估中的作用,指出子宫内膜厚度≤4 mm对子宫内膜癌的阴性预测值大于99%,可作为初步评估;对持续或复发出血者需进一步宫腔镜联合诊刮;无出血的绝经后妇女偶然发现内膜>4 mm无需常规评估,且经阴道超声不适用于无出血妇女的子宫内膜癌筛查。
要点
- 绝经后出血需及时评估以排除或诊断子宫内膜癌和子宫内膜上皮内瘤变。
- 内膜厚度≤4 mm对子宫内膜癌阴性预测值大于99%,经阴道超声通常足以初步评估。
- 经阴道超声不适用于无出血绝经后妇女的子宫内膜癌筛查。
核心结论
- 经阴道超声通常足以初步评估绝经后出血,尤其当内膜回声薄(≤4 mm)时,因内膜厚度≤4 mm对子宫内膜癌的阴性预测值大于99%。
研究设计与样本
- 美国妇产科医师学会(ACOG)委员会意见。
主要发现
- 阴道出血是超过90%的子宫内膜癌绝经后妇女的首发症状。
- 子宫内膜厚度≤4 mm对子宫内膜癌的阴性预测值大于99%。
- 无出血的绝经后患者偶然发现内膜测量值大于4 mm无需常规触发评估。
关键数值与推荐
- 经阴道超声通常足以初步评估绝经后出血,若超声图像显示内膜回声薄(≤4 mm)。
- 经阴道超声可作为子宫内膜取样之外的合理替代方案,用于评估首次出血发作的绝经后妇女。
- 若盲法取样未显示子宫内膜增生或恶性肿瘤,对持续或复发出血妇女需进一步检查如宫腔镜联合诊刮。
- 无出血绝经后患者偶然发现内膜测量值大于4 mm无需常规触发评估,但可基于患者特征和风险因素进行个体化评估。
- 经阴道超声不是无出血绝经后妇女子宫内膜癌的合适筛查工具。
临床怎么用
- 评估绝经后出血时应考虑子宫内膜癌临床风险因素,包括年龄、肥胖、无对抗雌激素使用、特定内科合并症(如多囊卵巢综合征、2型糖尿病、宫颈细胞学筛查示非典型腺细胞)及妇科恶性肿瘤家族史。
- 对首次出血发作的绝经后妇女,经阴道超声可作为子宫内膜取样之外的合理首选方法。
- 对持续或复发出血且盲法取样未显示增生或恶性者,需进一步宫腔镜联合诊刮。
- 无出血绝经后妇女偶然发现内膜>4 mm无需常规评估,但可个体化评估。
- 经阴道超声不应用于无出血绝经后妇女的子宫内膜癌筛查。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cancer of the endometrium is the most common type of gynecologic cancer in the United States. Vaginal bleeding is the presenting sign in more than 90% of postmenopausal women with endometrial carcinoma. Clinical risk factors for endometrial cancer, including but not limited to age, obesity, use of unopposed estrogen, specific medical comorbidities (eg, polycystic ovary syndrome, type 2 diabetes mellitus, atypical glandular cells on screening cervical cytology), and family history of gynecologic malignancy also should be considered when evaluating postmenopausal bleeding. The clinical approach to postmenopausal bleeding requires prompt and efficient evaluation to exclude or diagnose endometrial carcinoma and endometrial intraepithelial neoplasia. Transvaginal ultrasonography usually is sufficient for an initial evaluation of postmenopausal bleeding if the ultrasound images reveal a thin endometrial echo (less than or equal to 4 mm), given that an endometrial thickness of 4 mm or less has a greater than 99% negative predictive value for endometrial cancer. Transvaginal ultrasonography is a reasonable alternative to endometrial sampling as a first approach in evaluating a postmenopausal woman with an initial episode of bleeding. If blind sampling does not reveal endometrial hyperplasia or malignancy, further testing, such as hysteroscopy with dilation and curettage, is warranted in the evaluation of women with persistent or recurrent bleeding. An endometrial measurement greater than 4 mm that is incidentally discovered in a postmenopausal patient without bleeding need not routinely trigger evaluation, although an individualized assessment based on patient characteristics and risk factors is appropriate. Transvaginal ultrasonography is not an appropriate screening tool for endometrial cancer in postmenopausal women without bleeding.
引用
- ACOG Committee Opinion No. 734 Summary: The Role of Transvaginal Ultrasonography in Evaluating the Endometrium of Women With Postmenopausal Bleeding. Obstet Gynecol. 2018. PMID: 29683904. doi:10.1097/AOG.0000000000002626
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。